Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.84 |
| ▸ | RAD52 | P43351 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | DGKA | P23743 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 2/20 | 0.53 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.46 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL2254830 | 0.92 | NAAA (0.71) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL545172 | 0.92 | NAAA (1.00) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL1471551 | 0.92 | NAAA (1.00) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL1056018 | 0.92 | NAAA (1.00) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL21044637 | 0.92 | NAAA (1.00) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL112452 | 0.92 | NAAA (1.00) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL127979 | 0.92 | NAAA (1.00) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL9335976 | 0.92 | NAAA (1.00) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL5436011 | 0.92 | NAAA (1.00) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL21044673 | 0.92 | NAAA (1.00) | NAAARAD52NPSR1DGKAFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1606 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230225987-A1 | TOPICAL PHARMACEUTICAL COMPOSITIONS | Dermavant Sciences GmbH (CH) | 2023-07-20 | — | — | US | claimed |
| CN-116139029-A | Water-in-oil type cool itching-relieving ointment and preparation method thereof | 广州翀潇生物科技有限公司 | 2023-05-23 | — | — | CN | claimed |
| EP-4171529-A1 | TOPICAL PHARMACEUTICAL COMPOSITIONS | Dermavant Sciences GmbH (CH) | 2023-05-03 | — | — | EP | claimed |
| WO-2021262917-A1 | TOPICAL PHARMACEUTICAL COMPOSITIONS | Dermavant Sciences GmbH (CH) | 2021-12-30 | — | — | WO | claimed |
| EP-3820448-A2 | TOPICAL DETOMIDINE FORMULATIONS | Clexio Biosciences Ltd. (IL) | 2021-05-19 | — | — | EP | claimed |
| US-20210137830-A1 | TOPICAL DETOMIDINE FORMULATIONS | CLEXIO BIOSCIENCES LTD. (IL) | 2021-05-13 | — | — | US | claimed |
| EP-3496703-B1 | MOXIDECTIN TOPICAL LIQUID FORMULATIONS | NORBROOK LAB LTD (GB) | 2021-05-12 | — | — | EP | claimed |
| US-10675240-B2 | Transdermal cannabinoid formulations | MM TECHNOLOGY HOLDINGS, LLC (US) | 2020-06-09 | — | — | US | claimed |
| WO-2020067968-A1 | NEW COMPOSITIONS COMPRISING CATECHIN POLYPHENOLS | FARMETT LÄKEMEDEL AB (SE) | 2020-04-02 | — | — | WO | claimed |
| WO-2020012415-A2 | TOPICAL DETOMIDINE FORMULATIONS | CLEXIO BIOSCIENCES LTD. (IL) | 2020-01-16 | — | — | WO | claimed |
| US-6087393-A | PREVENTING FROM OXIDATION BY DISPERSING 1-ASCORBIC ACID IN A MIXED GLYCOL CARRIER INCLUDING PROPYLENE GLYCOL, BUTYLENE GLYCOL, AND A STABILIZER | IGEN, INC. (US) | 2000-07-11 | — | — | US | claimed |
| EP-0778765-A4 | COSMETIC MAKE-UP COMPOSITIONS | PROCTER & GAMBLE (US) | 2000-04-19 | — | — | EP | claimed |
| US-6013269-A | OIL-IN-WATER EMULSION COMPRISING VOLATILE SILICONE OIL AND/OR VOLATILE HYDROCARBON OIL, NON-VOLATILE OIL, PIGMENT AND ORGANIC AMPHIPHILIC MATERIAL CAPABLE OF FORMING SMECTIC LYOTROPIC LIQUID CRYSTALS IN PRODUCT OR ON THE SKIN | THE PROCTER & GAMBLE COMPANY (US) | 2000-01-11 | — | — | US | claimed |
| EP-0778765-A1 | COSMETIC MAKE-UP COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-06-18 | — | — | EP | claimed |
| EP-0432494-B1 | Pour-on formulations effective for the control of internal and external parasites of homothermic animals | AMERICAN CYANAMID CO (US) | 1997-02-05 | — | — | EP | claimed |
| WO-1996011665-A1 | COSMETIC MAKE-UP COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-04-25 | — | — | WO | claimed |
| EP-0432494-A2 | Pour-on formulations effective for the control of internal and external parasites of homothermic animals | AMERICAN CYANAMID COMPANY (US) | 1991-06-19 | — | — | EP | claimed |
| US-4889845-A | POLYDIMETHYLSILOXANE MIXTURE; STORAGE STABILITY; E-TYPE PROSTAGLANDINS | AMERICAN CYANAMID COMPANY (US) | 1989-12-26 | — | — | US | claimed |
| EP-0249193-A2 | Vehicle for topical application of pharmaceuticals | AMERICAN CYANAMID COMPANY (US) | 1987-12-16 | — | — | EP | claimed |
| EP-0249194-A2 | Topical prostaglandin formulations | AMERICAN CYANAMID COMPANY (US) | 1987-12-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10675240-B2 | Transdermal cannabinoid formulations | TNNC1, CNR2, TNNT2 | NAAA 781/4885RAD52 3867/4885NPSR1 1185/4885 |
| US-20230225987-A1 | TOPICAL PHARMACEUTICAL COMPOSITIONS | TSLP, SQLE, DHCR7 | NAAA 4128/4885RAD52 3738/4885NPSR1 3191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.